Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Retained Earnings: 2017-2018

Historic Retained Earnings for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to -$197.3 million.

  • Astria Therapeutics' Retained Earnings fell 13.46% to -$217.0 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$217.0 million, marking a year-over-year decrease of 13.46%. This contributed to the annual value of -$197.3 million for FY2018, which is 15.09% down from last year.
  • As of FY2018, Astria Therapeutics' Retained Earnings stood at -$197.3 million, which was down 15.09% from -$171.4 million recorded in FY2017.
  • Over the past 5 years, Astria Therapeutics' Retained Earnings peaked at -$171.4 million during FY2017, and registered a low of -$197.3 million during FY2018.
  • Moreover, its 2-year median value for Retained Earnings was -$184.4 million (2017), whereas its average is -$184.4 million.
  • Data for Astria Therapeutics' Retained Earnings shows a maximum YoY dropped of 15.09% (in 2018) over the last 5 years.
  • Astria Therapeutics' Retained Earnings (Yearly) stood at -$171.4 million in 2017, then fell by 15.09% to -$197.3 million in 2018.